Market Overview

Acacia Subsidiary Enters into Settlement Agreement with AstraZeneca

Share:
Related ACTG
Benzinga's Volume Movers
Mid-Day Market Update: Noodles & Co Slips On Downbeat Results; inContact Shares Climb
Best Performing Stocks On Earnings (Seeking Alpha)

Acacia Research Corporation (NASDAQ: ACTG) announced today that its
Accuhale LLC subsidiary has entered into a settlement agreement
regarding pressurized metered dose inhalers with AstraZeneca LP (NYSE: AZN),
AstraZeneca Pharmaceuticals LP, AstraZeneca Dunkerque Production SCS and
AstraZeneca AB. The agreement resolves litigation that was pending in
the United States District Court for the Eastern District of Texas.

See full press release

Posted-In: News Guidance Contracts Asset Sales Legal Management Global

 

Related Articles (ACTG + AZN)

Around the Web, We're Loving...